Contact

All Stories

  1. Fluoxetine and fractures after stroke: An individual patient data meta-analysis of three large randomized controlled trials of fluoxetine for stroke recovery

    Article • International Journal of Stroke, March 2025, SAGE Publications

    Associate Professor Erik Lundström

  2. Tenecteplase compared to alteplase in real-world outcome: A Swedish Stroke Register study

    Article • Upsala Journal of Medical Sciences, October 2024, Uppsala Medical Society

    Associate Professor Erik Lundström

  3. Individual patient data meta-analysis of the effects of fluoxetine on functional outcomes after acute stroke

    Article • International Journal of Stroke, April 2024, SAGE Publications

    Associate Professor Erik Lundström

  4. Is the difference real, is the difference relevant: the minimal detectable and clinically important changes in the Montreal Cognitive Assessment

    Article • Cerebral Circulation - Cognition and Behavior, January 2024, Elsevier

    Associate Professor Erik Lundström

  5. Does fluoxetine reduce apathetic and depressive symptoms after stroke? An analysis of the Efficacy oF Fluoxetine—a randomized Controlled Trial in Stroke trial data set

    Article • International Journal of Stroke, September 2022, SAGE Publications

    Associate Professor Erik Lundström

  6. Predictors of post-stroke cognitive impairment using acute structural MRI neuroimaging: A systematic review and meta-analysis

    Article • International Journal of Stroke, September 2022, SAGE Publications

    Associate Professor Erik Lundström

  7. Repeated Measures of Modified Rankin Scale Scores to Assess Functional Recovery From Stroke: AFFINITY Study Findings

    Article • Journal of the American Heart Association, August 2022, Wolters Kluwer Health

    Professor Leon Flicker, Associate Professor Erik Lundström

  8. Digital Graphic Follow-up Tool (Rehabkompassen) for Identifying Rehabilitation Needs Among People After Stroke: Randomized Clinical Feasibility Study

    Article • JMIR Human Factors, July 2022, JMIR Publications Inc.

    Associate Professor Erik Lundström

  9. Statistical analysis plan for the randomized controlled trial Tenecteplase in Wake-up Ischaemic Stroke Trial (TWIST)

    Article • Trials, May 2022, Springer Science + Business Media

    Associate Professor Erik Lundström

  10. Evaluating Rehabkompassen® - A Digital Graphic Follow-up Tool for Identifying Rehabilitation Needs Among People With Stroke: A Randomized Clinical Feasibility Study (Preprint)

    Article • April 2022, JMIR Publications Inc.

    Associate Professor Erik Lundström

  11. Complete functional recovery in a child after endovascular treatment of basilar artery occlusion caused by spontaneous dissection: a case report

    Article • Child s Nervous System, December 2021, Springer Science + Business Media

    Associate Professor Erik Lundström

  12. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery

    Article • Cochrane Database of Systematic Reviews, November 2021, Wiley

    Associate Professor Erik Lundström

  13. Effects of Fluoxetine on Outcomes at 12 Months After Acute Stroke

    Article • Stroke, October 2021, Wolters Kluwer Health

    Associate Professor Erik Lundström

  14. Potential effects on cardiometabolic risk factors and body composition by short message service (SMS)-guided training after recent minor stroke or transient ischaemic attack: post hoc analyses of the STROKEWALK randomised controlled trial

    Article • BMJ Open, October 2021, BMJ

    Associate Professor Erik Lundström

  15. Predicting post-stroke cognitive impairment using acute CT neuroimaging: A systematic review and meta-analysis

    Article • International Journal of Stroke, September 2021, SAGE Publications

    Associate Professor Erik Lundström

  16. Twelve-Month Outcomes of the AFFINITY Trial of Fluoxetine for Functional Recovery After Acute Stroke: AFFINITY Trial Steering Committee on Behalf of the AFFINITY Trial Collaboration

    Article • Stroke, August 2021, Wolters Kluwer Health

    Professor Leon Flicker, Associate Professor Erik Lundström

  17. Development of a short-form Swedish version of the Montreal Cognitive Assessment (s-MoCA-SWE): protocol for a cross-sectional study

    Article • BMJ Open, May 2021, BMJ

    Associate Professor Erik Lundström

  18. Levels of physical activity before and after stroke in relation to early cognitive function

    Article • Scientific Reports, April 2021, Springer Science + Business Media

    Associate Professor Erik Lundström

  19. Enhancing Recruitment Using Teleconference and Commitment Contract (ERUTECC): a stepped wedge cluster randomised trial within the EFFECTS trial

    Article • April 2021, Springer Science + Business Media

    Associate Professor Erik Lundström

  20. Update to the FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: statistical analysis plan for the trials and for the individual patient data meta-analysis

    Article • Trials, November 2020, Springer Science + Business Media

    Associate Professor Erik Lundström

  21. Trends in stroke reperfusion treatment and outcomes in New Zealand

    Article • Internal Medicine Journal, November 2020, Wiley

    Associate Professor Erik Lundström

  22. Effects on walking performance and lower body strength by short message service guided training after stroke or transient ischemic attack (The STROKEWALK Study): a randomized controlled trial

    Article • Clinical Rehabilitation, September 2020, SAGE Publications

    Associate Professor Erik Lundström

  23. Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial

    Article • The Lancet Neurology, August 2020, Elsevier

    Professor Leon Flicker, Associate Professor Erik Lundström

  24. Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial

    Article • The Lancet Neurology, August 2020, Elsevier

    Associate Professor Erik Lundström

  25. Selective Serotonin Reuptake Inhibitors for Stroke Recovery

    Article • Stroke, August 2020, Wolters Kluwer Health

    Associate Professor Erik Lundström

  26. Stroke survivors’ priorities for research related to life after stroke

    Article • Topics in Stroke Rehabilitation, July 2020, Taylor & Francis

    Associate Professor Erik Lundström

  27. Correction to: Update on the EFFECTS study of fluoxetine for stroke recovery: a randomised controlled trial in Sweden

    Article • Trials, May 2020, Springer Science + Business Media

    Associate Professor Erik Lundström

  28. Fluoxetine to improve functional outcomes in patients after acute stroke: the FOCUS RCT

    Article • Health Technology Assessment, May 2020, National Institute for Health Research

    Associate Professor Erik Lundström

  29. Update on the EFFECTS study of fluoxetine for stroke recovery: a randomised controlled trial in Sweden

    Article • Trials, February 2020, Springer Science + Business Media

    Associate Professor Erik Lundström

  30. Validation of the Simplified Modified Rankin Scale Questionnaire

    Article • European Neurology, January 2020, Karger Publishers

    Associate Professor Erik Lundström

  31. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery

    Article • Cochrane Database of Systematic Reviews, November 2019, Wiley

    Associate Professor Erik Lundström

  32. What are the important barriers to recruitment in randomised clinical studies?

    Article • Trials, October 2019, Springer Science + Business Media

    Associate Professor Erik Lundström

  33. Fluoxetine for stroke recovery: Meta-analysis of randomized controlled trials

    Article • International Journal of Stroke, October 2019, SAGE Publications

    Associate Professor Erik Lundström

  34. Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11–13 November 2018

    Article • European Stroke Journal, September 2019, SAGE Publications

    Associate Professor Erik Lundström

  35. Fluoxetine - a common antidepressant medication - seems to increase the risk for fractures in stroke

    Article • Stroke, August 2019, Wolters Kluwer Health

    Associate Professor Erik Lundström

  36. Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial

    Article • The Lancet, January 2019, Elsevier

    Associate Professor Erik Lundström, Professor Malcolm R Macleod, Frank Sullivan, Dr William D Strain, Alison McLoughlin, Professor Marian C Brady

  37. Effect of IV alteplase on the ischemic brain lesion at 24–48 hours after ischemic stroke

    Article • Neurology, November 2018, Wolters Kluwer Health

    Associate Professor Erik Lundström

  38. Trends in diagnosis-specific work disability before and after ischaemic heart disease: a nationwide population-based cohort study in Sweden

    Article • BMJ Open, April 2018, BMJ

    Associate Professor Erik Lundström

  39. Long-term health-related quality of life, survival and costs by different levels of functional outcome six months after stroke

    Article • European Stroke Journal, January 2018, SAGE Publications

    Ann-Sofie Rudberg, Associate Professor Erik Lundström

  40. Enhancing Recruitment Using Teleconference and Commitment Contract (ERUTECC): study protocol for a randomised, stepped-wedge cluster trial within the EFFECTS trial

    Article • Trials, January 2018, Springer Science + Business Media

    Associate Professor Erik Lundström

  41. Trends in Diagnosis‐Specific Work Disability Before and After Stroke: A Longitudinal Population‐Based Study in Sweden

    Article • Journal of the American Heart Association, January 2018, Wolters Kluwer Health

    Associate Professor Erik Lundström

  42. The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: statistical and health economic analysis plan for the trials and for the individual patient data meta-analysis

    Article • Trials, December 2017, Springer Science + Business Media

    Associate Professor Erik Lundström

  43. Validation of Serial Alberta Stroke Program Early CT Score as an Outcome Predictor in Thrombolyzed Stroke Patients

    Article • Journal of Stroke and Cerebrovascular Diseases, October 2017, Elsevier

    Associate Professor Erik Lundström

  44. Permanent work disability before and after ischaemic heart disease or stroke event: a nationwide population-based cohort study in Sweden

    Article • BMJ Open, September 2017, BMJ

    Associate Professor Erik Lundström

  45. Nongated Cardiac Computed Tomographic Angiograms for Detection of Embolic Sources in Acute Ischemic Stroke

    Article • Stroke, May 2017, Wolters Kluwer Health

    Associate Professor Erik Lundström

  46. Work disability before and after a major cardiovascular event: a ten-year study using nationwide medical and insurance registers

    Article • Scientific Reports, April 2017, Springer Science + Business Media

    Associate Professor Erik Lundström

  47. Recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 13–15 November 2016

    Article • European Stroke Journal, March 2017, SAGE Publications

    Associate Professor Erik Lundström

  48. Synchronous cardiocerebral infarction in the era of endovascular therapy: which to treat first?

    Article • Journal of Thrombosis and Thrombolysis, February 2017, Springer Science + Business Media

    Associate Professor Erik Lundström

  49. Arterial Obstruction on Computed Tomographic or Magnetic Resonance Angiography and Response to Intravenous Thrombolytics in Ischemic Stroke

    Article • Stroke, February 2017, Wolters Kluwer Health

    Associate Professor Erik Lundström

  50. Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial

    Article • The Lancet Neurology, September 2016, Elsevier

    Associate Professor Erik Lundström

  51. Predicting return to work after subarachnoid hemorrhage using the Montreal Cognitive Assessment (MoCA)

    Article • Acta Neurochirurgica, December 2015, Springer Science + Business Media

    Associate Professor Erik Lundström

  52. How common is isolated dysphasia among patients with stroke treated with intravenous thrombolysis, and what is their outcome? Results from the SITS-ISTR

    Article • BMJ Open, November 2015, BMJ

    Associate Professor Erik Lundström

  53. The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: a study protocol for three multicentre randomised controlled trials

    Article • Trials, August 2015, Springer Science + Business Media

    Associate Professor Erik Lundström

  54. Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial

    Article • The Lancet Neurology, May 2015, Elsevier

    Associate Professor Erik Lundström

  55. Attention Deficits After Aneurysmal Subarachnoid Hemorrhage Measured Using the Test of Variables of Attention

    Article • Stroke, March 2015, Wolters Kluwer Health

    Associate Professor Erik Lundström

  56. Establishing the effect(s) and safety of Fluoxetine initiated in the acute phase of stroke

    Article • December 2014, Springer Science + Business Media

    Associate Professor Erik Lundström

  57. Prevalence of spasticity after aneurysmal subarachnoid haemorrhage

    Article • Journal of Rehabilitation Medicine, January 2014, Acta Dermato-Venereologica

    Associate Professor Erik Lundström

  58. Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial

    Article • The Lancet Neurology, August 2013, Elsevier

    Associate Professor Erik Lundström

  59. Agreement between ambulance nurses and physicians in assessing stroke patients

    Article • Acta Neurologica Scandinavica, May 2013, Wiley

    Associate Professor Erik Lundström

  60. Letter by Mead et al Regarding Article, "Selective Serotonin Reuptake Inhibitors for Stroke: More Trials are Needed"

    Article • Stroke, April 2013, Wolters Kluwer Health

    Associate Professor Erik Lundström

  61. Health-related quality of life at median 12 months after aneurysmal subarachnoid hemorrhage, measured with EuroQoL-5D

    Article • Acta Neurochirurgica, January 2013, Springer Science + Business Media

    Associate Professor Erik Lundström

  62. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

    Article • The Lancet, June 2012, Elsevier

    Professor Malcolm R Macleod, Dr William D Strain, Associate Professor Erik Lundström

  63. Migrainous Infarction: Aspects on Risk Factors and Therapy

    Article • Current Review of Pain, April 2012, Springer Science + Business Media

    Associate Professor Erik Lundström

  64. Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited

    Article • Trials, November 2011, Springer Science + Business Media

    Professor Malcolm R Macleod, Associate Professor Erik Lundström

  65. Outcome After Spontaneous Subarachnoid Hemorrhage Measured With the EQ-5D

    Article • Stroke, November 2011, Wolters Kluwer Health

    Associate Professor Erik Lundström

  66. Response to Letter by Dobkin

    Article • Stroke, July 2010, Wolters Kluwer Health

    Associate Professor Erik Lundström

  67. International Comparisons of Stroke Costs Are Always Limited

    Article • Stroke, July 2010, Wolters Kluwer Health

    Associate Professor Erik Lundström

  68. Four-Fold Increase in Direct Costs of Stroke Survivors With Spasticity Compared With Stroke Survivors Without Spasticity

    Article • Stroke, February 2010, Wolters Kluwer Health

    Associate Professor Erik Lundström

  69. Time-course and determinants of spasticity during the first six months following first-ever stroke

    Article • Journal of Rehabilitation Medicine, January 2010, Acta Dermato-Venereologica

    Associate Professor Erik Lundström

  70. Risk factors for stroke-related pain 1 year after first-ever stroke

    Article • European Journal of Neurology, February 2009, Wiley

    Associate Professor Erik Lundström

  71. How common is disabling spasticity one year after first-ever stroke?

    Article • European Journal of Neurology, June 2008, Wiley

    Associate Professor Erik Lundström

  72. Objective assessment of cervical dystonia: a pilot study

    Article • Acta Neurologica Scandinavica, October 2005, Wiley

    Associate Professor Erik Lundström